triclabendazole has been researched along with Adverse Drug Event in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooles, S; Diesel, G; Dyer, F; Tait, A | 1 |
| Angles, R; Ault, SK; Barrientos, R; Barrios, G; Engels, D; Gabrielli, AF; Grueninger, H; Hamed, K; Mas-Coma, S; Montresor, A; Valero, MA; Villegas, F | 1 |
2 other study(ies) available for triclabendazole and Adverse Drug Event
| Article | Year |
|---|---|
Suspected adverse reactions, 2009.
Topics: Adverse Drug Reaction Reporting Systems; Animals; Anthelmintics; Benzimidazoles; Cat Diseases; Cats; Dogs; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Meloxicam; Off-Label Use; Population Surveillance; Renal Insufficiency; Thiazines; Thiazoles; Triclabendazole; United Kingdom; Vaccination | 2010 |
Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano.
Topics: Adolescent; Animals; Anthelmintics; Benzimidazoles; Bolivia; Chemoprevention; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Endemic Diseases; Fasciola hepatica; Fascioliasis; Female; Humans; Interviews as Topic; Male; Treatment Outcome; Triclabendazole | 2012 |